Projects funded by the NCN

Semaglutide and neurodevelopment: investigating risks arising from prenatal exposure to a widely popular drug for diabet...

Call: OPUS 26 , Panel: NZ7

Principal investigator: dr Agnieszka Wnuk

Instytut Farmakologii PAN

Selective PPARγ modulation by amorfrutin B as a novel therapeutic approach to chemotherapy-induced damage to mammalian b...

Call: PRELUDIUM 22 , Panel: NZ7

Principal investigator: Bernadeta Angelika Pietrzak-Wawrzyńska

Instytut Farmakologii PAN

Prenatal epigenetic modyfication associated with both the mother's atopy and diet as a risk factor for IgE dependent foo...

Call: OPUS 10 , Panel: NZ5

Principal investigator: dr Hanna Danielewicz

Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Lekarski

Identification of molecular profile of pediatric ependymomas according to gene expression status and epigenetic alterati...

Call: OPUS 1 , Panel: NZ4

Principal investigator: dr hab. Magdalena Izabela Zakrzewska

Uniwersytet Medyczny w Łodzi, Wydział Lekarski